Edition:
United Kingdom

ProQR Therapeutics NV (PRQR.OQ)

PRQR.OQ on NASDAQ Stock Exchange Global Market

15.17USD
23 Jan 2019
Change (% chg)

$-0.42 (-2.69%)
Prev Close
$15.59
Open
$15.60
Day's High
$16.00
Day's Low
$15.11
Volume
34,698
Avg. Vol
106,872
52-wk High
$24.00
52-wk Low
$2.80

Select another date:

Wed, Sep 5 2018

ProQR soars as childhood blindness drug succeeds in early trial

Shares of ProQR Therapeutics NV surged 70 percent in premarket trading on Tuesday after an interim analysis of an early-stage trial showed that its experimental treatment for a rare form of childhood blindness improved vision.

UPDATE 1-ProQR soars as childhood blindness drug succeeds in early trial

Sept 5 Shares of ProQR Therapeutics NV surged 70 percent in premarket trading on Tuesday after an interim analysis of an early-stage trial showed that its experimental treatment for a rare form of childhood blindness improved vision.

ProQR drug for rare childhood blindness succeeds in early trial

Sept 5 Dutch drug developer ProQR Therapeutics NV said on Tuesday its interim analysis showed that an early-stage trial of an experimental treatment for a rare form of childhood blindness was successful in improving vision.

Select another date: